Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medicinova (MNOV) Shares Outstanding (2021 - 2025)

Medicinova (MNOV) has disclosed Shares Outstanding for 6 consecutive years, with $49.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Shares Outstanding changed N/A to $49.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $49.2 million, a N/A change, with the full-year FY2025 number at $49.2 million, changed N/A from a year prior.
  • Shares Outstanding was $49.2 million for Q4 2025 at Medicinova, roughly flat from $49.0 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $49.2 million in Q4 2025 to a low of $48.8 million in Q1 2021.
  • A 5-year average of $49.0 million and a median of $49.0 million in 2022 define the central range for Shares Outstanding.
  • Peak YoY movement for Shares Outstanding: grew 0.56% in 2022, then changed 0.0% in 2023.
  • Medicinova's Shares Outstanding stood at $49.0 million in 2021, then increased by 0.01% to $49.0 million in 2022, then changed by 0.0% to $49.0 million in 2023, then changed by 0.0% to $49.0 million in 2024, then rose by 0.36% to $49.2 million in 2025.
  • Per Business Quant, the three most recent readings for MNOV's Shares Outstanding are $49.2 million (Q4 2025), $49.0 million (Q3 2025), and $49.0 million (Q2 2025).